Sotera Health (SHC) Company is presenting at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health’s business. “Sotera Health continued its solid growth trajectory in 2025, with revenue expected to surpass $1.16 billion, an increase of at least 5.5% year over year, or 5.0% on a constant-currency basis,” said CEO Michael B. Petras, Jr. “This marks over two decades of year-over-year revenue growth, reflecting the durability of our business model, the strength and consistency of our financial profile, and our continued commitment to serve our customers with excellence. We look forward to sharing our full-year results and 2026 outlook on February 24, 2026.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC:
- Sotera Health resumed with an Outperform at RBC Capital
- Sotera Health upgraded to Overweight from Neutral at Piper Sandler
- Sotera Health initiated with an Outperform at William Blair
- Sotera Health: Integrated Market Leadership, Easing Litigation Overhang, and Valuation Upside Support Buy Rating
- Sotera Health 16.2M share Block Trade priced at $16.50
